Jack Griffin is a Vice President focused on primary investments in third-party CLO funds, as well as the structuring and origination of Carlyle-sponsored CLO funds. He is based in New York. Prior to joining Carlyle in 2018, Mr. Griffin was at MUFG Securities where he specialized in the structuring and origination of CLOs. Mr. Griffin started his career at Ernst & Young LLP in their Structured Finance Valuations Group.
Mr. Griffin received his B.A. in economics from Connecticut College and maintains Series 7, 63, and 79 licenses.
Let's spread the word about Immunotherapy! Click to share this page with your community.